Efficacy of Acupuncture in Exercise Tolerance in Patients With COPD

December 5, 2018 updated by: Carla Manuela Loureiro Barros, Instituto de Ciências Biomédicas Abel Salazar

Efficacy of Acupuncture in Exercise Tolerance in Patients With COPD Controlled, Randomized, Double Blind Study

Chronic Obstructive Pulmonary Disease (COPD) is nowadays the 4th cause of death in the world and it´s expected to become the 3rd cause of death in 2020 and the majority cause of morbidity. Besides that, in Portugal COPD patients become more dependents each day.

Acupuncture as a reflex therapy it´s carried out through a Traditional Chinese Medicine (TCM) diagnose that will allowed to identify the acupoints.

The investigators are interested in to assess acupuncture efficacy on physical exercise tolerance in COPD patients.An experimental, controlled, randomized, double blind study was done. Patients were recruited according TCM diagnose to optimize potential therapeutic effects.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

29

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Porto
      • Marco de Canaveses, Porto, Portugal, 4635 670
        • Carla Manuela Loureiro Barros

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 90 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • COPD GOLD III,IV;
  • able to walk;
  • Informed consent signed;
  • stable medication during last 3 days
  • exacerbation during 3 months;
  • Chinese diagnose opening principle;
  • blood pressure "90"180 mmhg/ "100mmhg; respiratory rate "10"30 cpm

Exclusion Criteria:

  • smoker;
  • metastasis;
  • hepatic,
  • renal or cardiovascular disease;
  • pulmonary hypertension;
  • COPD symptoms exacerbation during the therapy;
  • previous acupuncture treatments;
  • unstable vital signs;
  • pulmonary rehabilitation in the last 6 months;
  • needle phobia.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Sham Comparator: sham acupuncture
False acupuncture treatment using not acupuncture points
The patients were randomized in two groups, one verum acupuncture, submitted to real acupuncture treatment, and the other sham acupuncture, treated with false acupuncture
Experimental: Verum acupucnture
Real acupuncture treatment
The patients were randomized in two groups, one verum acupuncture, submitted to real acupuncture treatment, and the other sham acupuncture, treated with false acupuncture

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
six minute walk test (6MWT)
Time Frame: 6 minutes
distance walked (metres)
6 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Oxygen peripheral saturation (SPO2)
Time Frame: 6 minutes
pulse oximeter
6 minutes
Rating of perceived exertion (Borg Scale)
Time Frame: 6 minutes
during 6MWT
6 minutes
Blood pressure
Time Frame: 6 minutes
measure at end of 6MWT
6 minutes
heart rate
Time Frame: 6 minutes
at end of 6MWT
6 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Henry Greten, Doctor, Abel Salazar Institute of Biomedical Sciences, University of Porto

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 27, 2018

Primary Completion (Actual)

September 25, 2018

Study Completion (Actual)

November 28, 2018

Study Registration Dates

First Submitted

December 5, 2018

First Submitted That Met QC Criteria

December 5, 2018

First Posted (Actual)

December 6, 2018

Study Record Updates

Last Update Posted (Actual)

December 7, 2018

Last Update Submitted That Met QC Criteria

December 5, 2018

Last Verified

December 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • acupuncture

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pulmonary Disease, Chronic Obstructive

Clinical Trials on acupuncture

Subscribe